These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

503 related articles for article (PubMed ID: 19412163)

  • 1. Frequent inactivation of A20 in B-cell lymphomas.
    Kato M; Sanada M; Kato I; Sato Y; Takita J; Takeuchi K; Niwa A; Chen Y; Nakazaki K; Nomoto J; Asakura Y; Muto S; Tamura A; Iio M; Akatsuka Y; Hayashi Y; Mori H; Igarashi T; Kurokawa M; Chiba S; Mori S; Ishikawa Y; Okamoto K; Tobinai K; Nakagama H; Nakahata T; Yoshino T; Kobayashi Y; Ogawa S
    Nature; 2009 Jun; 459(7247):712-6. PubMed ID: 19412163
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A20 (TNFAIP3) deletion in Epstein-Barr virus-associated lymphoproliferative disorders/lymphomas.
    Ando M; Sato Y; Takata K; Nomoto J; Nakamura S; Ohshima K; Takeuchi T; Orita Y; Kobayashi Y; Yoshino T
    PLoS One; 2013; 8(2):e56741. PubMed ID: 23418597
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TNFAIP3 (A20) is a tumor suppressor gene in Hodgkin lymphoma and primary mediastinal B cell lymphoma.
    Schmitz R; Hansmann ML; Bohle V; Martin-Subero JI; Hartmann S; Mechtersheimer G; Klapper W; Vater I; Giefing M; Gesk S; Stanelle J; Siebert R; Küppers R
    J Exp Med; 2009 May; 206(5):981-9. PubMed ID: 19380639
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TNFAIP3/A20 functions as a novel tumor suppressor gene in several subtypes of non-Hodgkin lymphomas.
    Honma K; Tsuzuki S; Nakagawa M; Tagawa H; Nakamura S; Morishima Y; Seto M
    Blood; 2009 Sep; 114(12):2467-75. PubMed ID: 19608751
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Downstream activation of NF-κB in the EDA-A1/EDAR signalling in Sjögren's syndrome and its regulation by the ubiquitin-editing enzyme A20.
    Sisto M; Barca A; Lofrumento DD; Lisi S
    Clin Exp Immunol; 2016 May; 184(2):183-96. PubMed ID: 26724675
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A20 (TNFAIP3) genetic alterations in EBV-associated AIDS-related lymphoma.
    Giulino L; Mathew S; Ballon G; Chadburn A; Barouk S; Antonicelli G; Leoncini L; Liu YF; Gogineni S; Tam W; Cesarman E
    Blood; 2011 May; 117(18):4852-4. PubMed ID: 21406721
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The seventh zinc finger motif of A20 is required for the suppression of TNF-α-induced apoptosis.
    Yamaguchi N; Yamaguchi N
    FEBS Lett; 2015 May; 589(12):1369-75. PubMed ID: 25911380
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Specific recognition of linear polyubiquitin by A20 zinc finger 7 is involved in NF-κB regulation.
    Tokunaga F; Nishimasu H; Ishitani R; Goto E; Noguchi T; Mio K; Kamei K; Ma A; Iwai K; Nureki O
    EMBO J; 2012 Oct; 31(19):3856-70. PubMed ID: 23032187
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutations in the genes coding for the NF-κB regulating factors IκBα and A20 are uncommon in nodular lymphocyte-predominant Hodgkin's lymphoma.
    Schumacher MA; Schmitz R; Brune V; Tiacci E; Döring C; Hansmann ML; Siebert R; Küppers R
    Haematologica; 2010 Jan; 95(1):153-7. PubMed ID: 19648161
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spontaneous NF-κB activation by autocrine TNFα signaling: a computational analysis.
    Pękalski J; Zuk PJ; Kochańczyk M; Junkin M; Kellogg R; Tay S; Lipniacki T
    PLoS One; 2013; 8(11):e78887. PubMed ID: 24324544
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutations of multiple genes cause deregulation of NF-kappaB in diffuse large B-cell lymphoma.
    Compagno M; Lim WK; Grunn A; Nandula SV; Brahmachary M; Shen Q; Bertoni F; Ponzoni M; Scandurra M; Califano A; Bhagat G; Chadburn A; Dalla-Favera R; Pasqualucci L
    Nature; 2009 Jun; 459(7247):717-21. PubMed ID: 19412164
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The ubiquitin-editing enzyme A20 (TNFAIP3) is a central regulator of immunopathology.
    Vereecke L; Beyaert R; van Loo G
    Trends Immunol; 2009 Aug; 30(8):383-91. PubMed ID: 19643665
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A20 is an early responding negative regulator of Toll-like receptor 5 signalling in intestinal epithelial cells during inflammation.
    Oshima N; Ishihara S; Rumi MA; Aziz MM; Mishima Y; Kadota C; Moriyama I; Ishimura N; Amano Y; Kinoshita Y
    Clin Exp Immunol; 2010 Feb; 159(2):185-98. PubMed ID: 19912257
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bcl10 is an essential regulator for A20 gene expression.
    Xu W; Xue L; Sun Y; Henry A; Battle JM; Micault M; Morris SW
    J Physiol Biochem; 2013 Dec; 69(4):821-34. PubMed ID: 23677497
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deubiquitinating enzyme A20 negatively regulates NF-κB signaling in skeletal muscle in mdx mice.
    Charan RA; Hanson R; Clemens PR
    FASEB J; 2012 Feb; 26(2):587-95. PubMed ID: 22012122
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A20/TNFAIP3 inhibits NF-κB activation induced by the Kaposi's sarcoma-associated herpesvirus vFLIP oncoprotein.
    Sakakibara S; Espigol-Frigole G; Gasperini P; Uldrick TS; Yarchoan R; Tosato G
    Oncogene; 2013 Mar; 32(10):1223-32. PubMed ID: 22525270
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The NF-{kappa}B negative regulator TNFAIP3 (A20) is inactivated by somatic mutations and genomic deletions in marginal zone lymphomas.
    Novak U; Rinaldi A; Kwee I; Nandula SV; Rancoita PM; Compagno M; Cerri M; Rossi D; Murty VV; Zucca E; Gaidano G; Dalla-Favera R; Pasqualucci L; Bhagat G; Bertoni F
    Blood; 2009 May; 113(20):4918-21. PubMed ID: 19258598
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of NF-κB signaling by the A20 deubiquitinase.
    Shembade N; Harhaj EW
    Cell Mol Immunol; 2012 Mar; 9(2):123-30. PubMed ID: 22343828
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An enhancer element harboring variants associated with systemic lupus erythematosus engages the TNFAIP3 promoter to influence A20 expression.
    Wang S; Wen F; Wiley GB; Kinter MT; Gaffney PM
    PLoS Genet; 2013; 9(9):e1003750. PubMed ID: 24039598
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of the NF-κB inhibitor A20 as a key regulator for human adipogenesis.
    Dorronsoro A; Lang V; Jakobsson E; Ferrin I; Salcedo JM; Fernández-Rueda J; Fechter K; Rodriguez MS; Trigueros C
    Cell Death Dis; 2013 Dec; 4(12):e972. PubMed ID: 24357803
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.